Keros Therapeutics, Inc.KROSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank71
3Y CAGR+1.0%
5Y CAGR+1.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+1.0%/yr
vs +86.1%/yr prior
5Y CAGR
+1.6%/yr
Consistent
Acceleration
-85.1pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $287.42M | -48.7% |
| 2024 | $559.93M | +69.1% |
| 2023 | $331.15M | +18.7% |
| 2022 | $279.05M | +21.3% |
| 2021 | $230.04M | -13.5% |
| 2020 | $265.88M | +3687.4% |
| 2019 | $7.02M | -69.8% |
| 2018 | $23.26M | - |